News Results for Smith & Nephew (SN.)

UBS today reaffirms its neutral investment rating on Smith & Nephew PLC (LON:SN.) and raised its price target to 1830p (from 1730p). Story provided by StockMarketWire.com Broker Forecasts...

Berenberg today reaffirms its buy investment rating on Smith & Nephew PLC (LON:SN.) and raised its price target to 2265p (from 2210p). Story provided by StockMarketWire.com Broker Forecasts...

Medical equipment manufacturer Smith & Nephew said it had raised its full-year revenue guidance amid 'positive momentum' across the business globally in the first half of 2019. It now expected...

UBS today reaffirms its neutral investment rating on Smith & Nephew PLC (LON:SN.) and raised its price target to 1730p (from 1455p). Story provided by StockMarketWire.com Broker Forecasts...

Smith & Nephew said it had completed the acquisition of Swiss optical tracking technology provider Atracsys Sarl, or an undisclosed sum. The medical devices company said the acquisition...

Angie Risley, Non Executive Director, bought 2,380 shares in the company on the 27th June 2019 at a price of 1673.56p. The Director now holds 4,340 shares representing 0.00% of the shares in...

Medical technology company Smith & Nephew said it had agreed to acquire Switzerland-based provider of optical tracking technology Atracsys Sarl, for an undisclosed sum. Atracsys Sarl's...

Shore Capital today downgrades its investment rating on Smith & Nephew PLC (LON:SN.) to sell (from hold). Story provided by StockMarketWire.com Broker Forecasts data provided by...

Medical technology group Smith & Nephew said it had completed its acquisition of the Brainlab orthopaedic joint reconstruction business, for an undisclosed sum. The acquisition supported Smith...

JP Morgan Cazenove today reaffirms its neutral investment rating on Smith & Nephew PLC (LON:SN.) and raised its price target to 1758p (from 1689p). Story provided by StockMarketWire.com...

Roland Digglemann, Non Executive Director, bought 1,540 shares in the company on the 3rd May 2019 at a price of 1532.11p. The Director now holds 6,407 shares representing 0.00% of the shares in...

By midday the FTSE 100 was virtually unchanged at 7,385.04 as the Bank of England's Monetary Policy Committee voted unanimously to keep interest rates at 0.75%. US futures pointed to a rebound on...

Smith & Nephew said it had completed its acquisition of regenerative medicine products supplier Osiris for around $660m. The medical technology group had offered $19.00 per Osiris share in...

Smith & Nephew said it had agreed to acquire Leaf Healthcare, a developer of a system for pressure injury prevention and patient mobility monitoring, for an undisclosed sum. The transaction...

Medical technology group Smith & Nephew said its next generation surgical robots platform was planned for completion in late 2019. A full commercial release was then slated for 2020. The...

Medical technology company Smith & Nephew said it had agreed to acquire regenerative medicine group Osiris Therapeutics for around $660m. Osiris Therapeutics offered products including skin,...

UK economic growth slowed in December, prompting a fall in sterling, which was a catalyst the FTSE 100 as it boosts the relative value of its constituents' largely overseas earnings. The FTSE...

Goldman Sachs today reaffirms its neutral investment rating on Smith & Nephew PLC (LON:SN.) and raised its price target to 1440p (from 1400p). Story provided by StockMarketWire.com Broker...

JP Morgan Cazenove today reaffirms its neutral investment rating on Smith & Nephew PLC (LON:SN.) and raised its price target to 1516p (from 1477p). Story provided by StockMarketWire.com...

Credit Suisse today reaffirms its neutral investment rating on Smith & Nephew PLC (LON:SN.) and raised its price target to 1390p (from 1330p). Story provided by StockMarketWire.com Broker...

Exane BNP Paribas today downgrades its investment rating on Smith & Nephew PLC (LON:SN.) to neutral (from outperform) and raised its price target to 1525p (from 1475p). Story provided by...

Amid a raft of corporate news, weak economic forecasts from Europe and continued volatility in sterling the FTSE 100 trades lower. Approaching midday the index was down 0.3% to 7,152.44. Other...

British medical equipment manufacturer Smith & Nephew posted a small increase in revenue in its full-year results on Thursday as it said it did not anticipate any significant impact on its...

UBS today reaffirms its neutral investment rating on Smith & Nephew PLC (LON:SN.) and raised its price target to 1390p (from 1340p). Story provided by StockMarketWire.com Broker Forecasts...

JP Morgan Cazenove today downgrades its investment rating on Smith & Nephew PLC (LON:SN.) to neutral (from overweight). Story provided by StockMarketWire.com Broker Forecasts data provided by...

Morgan Stanley today upgrades its investment rating on Smith & Nephew PLC (LON:SN.) to overweight (from equal weight) and raised its price target to 1692p (from 1457p). Story provided by...

Deutsche Bank today upgrades its investment rating on Smith & Nephew PLC (LON:SN.) to hold (from sell) and raised its price target to 1350p (from 1200p). Story provided by StockMarketWire.com...

Berenberg today reaffirms its hold investment rating on Smith & Nephew PLC (LON:SN.) and raised its price target to 1475p (from 1370p). Story provided by StockMarketWire.com Broker Forecasts...

Reports of a Brexit deal for the UK financial services sector kept the pound sky high, pushing the FTSE 100 lower by 0.2% to 7,114. Oil prices sharply dropped 2.9% to $72.85 per barrel on reports...

Strength in the pound on reports of a Brexit deal for the UK financial services sector as well as pressure on commodities meant the FTSE 100 lagged a strong showing elsewhere in Europe. Though by...

UK stocks are edging lower on Thursday morning ahead of the Bank of England's interest rate decision later in the session and as dollar-denominated FTSE firms suffered from sterling strength. At...

Global medical technology business Smith & Nephew reported a 3% increase in third-quarter underlying revenue and reconfirmed its full-year guidance as it implemented a new global commercial...

HSBC today downgrades its investment rating on Smith & Nephew PLC (LON:SN.) to hold (from buy) and cut its price target to 1400p (from 1500p). Story provided by StockMarketWire.com Broker...

UBS today downgrades its investment rating on Smith & Nephew PLC (LON:SN.) to neutral (from buy) and cut its price target to 1340p (from 1470p). Story provided by StockMarketWire.com Broker...

Graham Baker, Executive Director, bought 8,988 shares in the company on the 2nd August 2018 at a price of 1330.59p. The Director now holds 9,988 shares representing 0.00% of the shares in issue....

Numis today reaffirms its add investment rating on Smith & Nephew PLC (LON:SN.) and raised its price target to 1480p (from 1350p). Story provided by StockMarketWire.com Broker Forecasts data...

The FTSE 100 rose 0.1% to 7,668 around 9am as a raft of positive financial results from blue-chips helped offset weakness in the mining and oil sectors. Among the weakest performers was oil major...

Smith & Nephew delivered reported revenue growth of 4% in the three months to 30 June, including 2% currency tailwind, with underlying growth of 2%. The company said established markets...

UBS today reaffirms its buy investment rating on Smith & Nephew PLC (LON:SN.) and cut its price target to 1470p (from 1550p). Story provided by StockMarketWire.com Broker Forecasts data...

Deutsche Bank today downgrades its investment rating on Smith & Nephew PLC (LON:SN.) to sell (from hold) and cut its price target to 1200p (from 1315p). Story provided by StockMarketWire.com...

Trade war fears re-emerged on reports China imposed tariffs on US soybeans, prompting concerns the country will retaliate. On Wall Street, the Dow Jones dropped 1.5% to 23,572 around 4:45pm UK...

Jefferies International today reaffirms its buy investment rating on Smith & Nephew PLC (LON:SN.) and set its price target at 1515p. Story provided by StockMarketWire.com Broker Forecasts...

The FTSE 100 slipped into negative territory as weakness in insurers weighed on performance. Direct Line (DLG) shed 0.9% to 362.6p and RSA Insurance (RSA) fell 0.7% to 644.8p. The FTSE 100...

The FTSE 100 slipped marginally by 4.23 points to 7,358 on Thursday morning after the US Federal Reserve confirmed its plan to increase borrowing costs as inflation firms. Smith & Nephew...

Smith & Nephew, the medical equipment manufacturing company, has cut its full year underlying revenue growth forecast to 2-3%, with a trading profit margin at or above that achieved in 2017....

Deutsche Bank today reaffirms its hold investment rating on Smith & Nephew PLC (LON:SN.) and cut its price target to 1309.50p (from 1315p). Story provided by StockMarketWire.com Broker...

JP Morgan Cazenove today reaffirms its overweight investment rating on Smith & Nephew PLC (LON:SN.) and raised its price target to 1463p (from 1411p). Story provided by StockMarketWire.com...

HSBC today upgrades its investment rating on Smith & Nephew PLC (LON:SN.) to buy (from hold) and raised its price target to 1530p (from 1320p). Story provided by StockMarketWire.com Broker...

Olivier Bohuon, Chief Executive Officer, has transferred in 89,029 shares in the company on the 9th March 2018 at a price of 0.00p. The Director now holds 576,911 shares. NOTE: Vesting Story...

Olivier Bohuon, Chief Executive Officer, sold 41,992 shares in the company on the 9th March 2018 at a price of 1325.65p. The Director now holds 534,919 shares. NOTE: Sold to meet tax liabilities...

Olivier Bohuon, Chief Executive Officer, has transferred in 17,323 shares in the company on the 7th March 2018 at a price of 0.00p. The Director now holds 488,583 shares. Story provided by...

Olivier Bohuon, Chief Executive Officer, has transferred in 17,323 shares in the company on the 7th March 2018 at a price of 0.00p. The Director now holds 488,583 shares. Story provided by...

Graham Baker, Executive Director, bought 1,000 shares in the company on the 27th February 2018 at a price of 1283.33p. The Director now holds 1,000 shares representing 0.00% of the shares in...

Morgan Stanley today reaffirms its equal weight investment rating on Smith & Nephew PLC (LON:SN.) and cut its price target to 1457p (from 1558p). Story provided by StockMarketWire.com Broker...

Angie Risley, Non Executive Director, received in lieu of fees/salary 1,601 shares in the company on the 9th February 2018 at a price of 1248.93p. The Director now holds 1,601 shares representing...

Smith & Nephew has increased its full year dividend by 14% to 35c per share following strong growth earnings growth. Adjusted earnings per share increased 14% to 94.5c in 2017 as a result of...

Smith & Nephew said it had launched a new wound therapy system in Europe. The so-called PICO 7 product delivered a more efficient vacuum and better leak management, the company claimed. It...

Smith & Nephew has appointed Roland Diggelmann as a new non-executive director, effective March 1. Diggelmann is currently chief executive officer at Roche Diagnostics. At 9:54am: (LON:SN.)...

JP Morgan Cazenove today upgrades its investment rating on Smith & Nephew PLC (LON:SN.) to overweight (from neutral) and raised its price target to 1411p (from 1369p). Story provided by...

The FTSE 100 remained in positive territory, supported by gains in healthcare and airline stocks. The blue-chip index advanced 0.2% to 7,731. Low-cost airline EasyJet (EZJ) boosted sales by 14.4%...

Smith & Nephew said it expected to incur a corporate tax rate in the US in the range of 20%-to-21% following changes to country's tax regime. That would market a reduction of four-to-five...

Smith & Nephew has completed the acquisition of Rotation Medical, a developer of tissue regeneration technology for shoulder rotator cuff repair The acquisition cost was $125m with up to a...

Smith & Nephew said a trial has shown that the addition of its multi-layer polyurethane dressing significantly reduces the onset of pressure ulcers in elderly patients admitted to hospital for...

Olivier Bohuon, Chief Executive Officer, has re-invested 1,454 shares in the company on the 1st November 2017 at a price of 1402.86p. The Director now holds 471,260 shares. Story provided by...

Smith & Nephew has announced completion of the world's first robotics-assisted bi-cruciate retaining total knee replacement procedure. The NAVIO robotics-assisted surgical system aids in...

JP Morgan Cazenove today reaffirms its neutral investment rating on Smith & Nephew PLC (LON:SN.) and cut its price target to 1369p (from 1382p). Story provided by StockMarketWire.com

Smith & Nephew has confirmed that it will now commence its Quarterly Buy Back programme of 651,862 shares through Merrill Lynch. The Company said it intends to hold these shares in Treasury....

The FTSE 100 eased back in afternoon trading after the pound gained momentum on strong UK services data, the sector representing the lion's share of British economic output, and underwhelming jobs...

Olivier Bohuon, Chief Executive Officer, has re-invested 1,601 shares in the company on the 1st November 2017 at a price of 1402.87p. The Director now holds 469,806 shares. Story provided by...

Sterling was subdued after yesterday's sharp drop, but a strong performance in the mining sector helped the FTSE 100. Randgold Resources (RRS) and Fresnillo (FRES) rose 0.7% and 0.5%,...

Smith & Nephew said it now expected its full-year revenue and margin performance to be at the lower end of previous guidance, amid a 3% rise in third-quarter revenue. The medical equipment...

Financial stocks were weaker ahead of a raft of results from the sector this week, kicking off with Lloyds (LLOY) on Wednesday. Royal Bank of Scotland (RBS) fell 1% to 279.5p, while HSBC (HSBA)...

Smith & Nephew confirmed that it has entered into a definitive agreement to acquire Rotation Medical for an initial cash amount of $125m and up to an additional $85m over the next five years,...

Deutsche Bank today reaffirms its hold investment rating on Smith & Nephew PLC (LON:SN.) and raised its price target to 1315p (from 1200p). Story provided by StockMarketWire.com

Smith & Nephew has confirmed that the Company intends to announce its third quarter trading report on 3 November. At 1:10pm: (LON:SN.) Smith Nephew PLC share price was +17.5p at 1430.5p...

Smith & Nephew has confirmed that the previously announced interim dividend for 2017 of 12.3 US cents per Ordinary Share will be paid on 1 November 2017 to shareholders whose name appeared on...

JP Morgan Cazenove today reaffirms its neutral investment rating on Smith & Nephew PLC (LON:SN.) and raised its price target to 1382p (from 1361p). Story provided by StockMarketWire.com

Sterling weakened on a warning from Chancellor Phillip Hammond that flights could be grounded in the UK if no deal was sealed before leaving the European Union. Despite the decline in the value of...

The FTSE 100 drifted lower to 7,539 as small gains in utility firms failed to offset weakness in banking stocks. News that a price cap on energy bills would be unlikely to come into effect before...

An underwhelming performance from the mining sector and a stronger pound dragged on the FTSE 100, which closed 0.2% lower at 7,507. Miners struggled after activity in China's services sector grew...

Weakness in the mining sector weighed on the FTSE 100, which was struggling to gain positive momentum at 7,507. Rio Tinto (RIO), Anglo American (AAL) and Glencore (GLEN) dipped by up to 1.5% each....

Smith & Nephew said that chief executive Olivier Bohuon will retire by the end of 2018. The company's board is commencing a search for a successor. "Looking ahead to the next long-term phase...

JP Morgan Cazenove today reaffirms its neutral investment rating on Smith & Nephew PLC (LON:SN.) and raised its price target to 1361p (from 1280p). Story provided by StockMarketWire.com

Jefferies International today reaffirms its buy investment rating on Smith & Nephew PLC (LON:SN.) and raised its price target to 1515p (from 1350p). Story provided by StockMarketWire.com

AstraZeneca (AZN) crashed 16.2% to £42.83 on its failed MYSTIC clinical trial. The pharma giant said that using immuno-therapy drugs durvalumab and tremelimumab failed to help patients in the...

Smith & Nephew (SN.), the medical equipment manufacturing company, reported revenue of $1,194m for the second quarter, which was flat on a reported basis and up 3% when foreign exchange...

Story provided by StockMarketWire.com

Smith & Nephew has confirmed that the Company intends to announce its second quarter trading update and first half results for the period ended 1 July on Thursday 27 July. At 2:17pm:...

Smith & Nephew said Angie Risley is to join its board as non-executive director on 18 September 2017. Separately, Serco said Risley has notified its board of her intention to stand down as a...

Citigroup today reaffirms its sell investment rating on Smith & Nephew PLC (LON:SN.) and set its price target at 1160p. Story provided by StockMarketWire.com

Olivier Bohuon, Chief Executive Officer, has re-invested 2,397 shares in the company on the 15th May 2017 at a price of 1300.22p. The Director now holds 468,205 shares. Story provided by...

Smith & Nephew has confirmed that the group will commence its quarterly buy-back programme this week, which includes the purchase of 959,746 of its own shares through Merrill Lynch. At...

Olivier Bohuon, Chief Executive Officer, has re-invested 2,639 shares in the company on the 10th May 2017 at a price of 1300.22p. The Director now holds 465,808 shares. Story provided by...

Olivier Bohuon, Chief Executive Officer, has re-invested 2,639 shares in the company on the 10th May 2017 at a price of 1300.22p. The Director now holds 465,808 shares. Story provided by...

Olivier Bohuon, Chief Executive Officer, has re-invested 2,639 shares in the company on the 10th May 2017 at a price of 1300.22p. The Director now holds 465,808 shares. Story provided by...

Credit Suisse today reaffirms its neutral investment rating on Smith & Nephew PLC (LON:SN.) and raised its price target to 1200p (from 1160p). Story provided by StockMarketWire.com

JP Morgan Cazenove today reaffirms its neutral investment rating on Smith & Nephew PLC (LON:SN.) and cut its price target to 1280p (from 1345p). Story provided by StockMarketWire.com

Smith & Nephew said its Q1 2017 trading was in line with its expectations, and that it was on track to deliver 3-4% underlying revenue growth for the FY. CEO Olivier Bohuon said that in...

Story provided by StockMarketWire.com